STOCK TITAN

4Front Ventures Corp Stock Price, News & Analysis

FFNTF OTC

Welcome to our dedicated page for 4Front Ventures news (Ticker: FFNTF), a resource for investors and traders seeking the latest updates and insights on 4Front Ventures stock.

4Front Ventures Corp (FFNTF) operates as a vertically integrated cannabis enterprise with cultivation, manufacturing, and retail operations across strategic U.S. markets. This news hub provides investors and industry observers with essential updates on corporate developments, regulatory compliance milestones, and market expansions.

Our curated collection features official press releases covering financial results, facility openings, product innovations like vape technologies and pre-roll formats, and partnership announcements. Users will find timely updates on operational expansions in Illinois, Massachusetts, and Washington markets alongside wholesale distribution developments.

Key content categories include earnings disclosures, cultivation capacity updates, retail network growth, and management team changes. The resource serves as a centralized reference for tracking FFNTF's execution of its low-cost production strategy and retail brand development in evolving cannabis markets.

Bookmark this page for structured access to 4Front Ventures' verified corporate communications, maintained with strict adherence to factual reporting standards. Regular updates ensure stakeholders maintain current awareness of this multi-state operator's progress in competitive cannabis sectors.

Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) will announce its Q2 2022 financial results on August 15, 2022, after market close. A conference call is scheduled for 5:00 p.m. ET to discuss the results and current business trends. The company operates in strategic cannabis markets across the U.S. including California and Illinois. 4Front is recognized for its low-cost cultivation and a broad product lineup with over 1,800 products across more than 20 brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.17%
Tags
conferences earnings
-
Rhea-AI Summary

On June 9, 2022, 4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) announced several key leadership appointments, including a new Chief Financial Officer, General Counsel, President of California Operations, Executive Vice President, and two board members. Keith Adams joins as CFO, with a robust background in cannabis and tech industries. Christopher Wimmer takes up the General Counsel role, and Ray Landgraf becomes President of California Operations. The appointments aim to enhance long-term growth potential for the company, reflecting 4Front's commitment to strategic leadership in the cannabis sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.59%
Tags
management
-
Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) reported strong Q1 2022 results, with systemwide pro forma revenue rising 7% to $32.4 million and GAAP revenue up 13% to $26.1 million. The adjusted EBITDA surged 53% to $9.0 million, yielding an adjusted EBITDA margin of 28%. Key developments included completing the acquisition of New England Cannabis Corporation and signing an agreement to acquire Island Cannabis Co., enhancing the company's production capabilities in Massachusetts and California. The company aims to expand its market presence through a new facility in Illinois, projected to open in Q1 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.09%
Tags
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) will report its first-quarter financial results for the period ending March 31, 2022, on May 23, 2022, after market close. The company, a multi-state cannabis operator, will also host a conference call at 5:00 PM ET to discuss these results and current business trends. 4Front has established a strong reputation for low-cost cultivation and operates in key markets including California, Illinois, and Massachusetts, offering over 1800 products through its owned retail outlets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.6%
Tags
conferences earnings
-
Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF), a multi-state cannabis operator, announced its participation in several upcoming conferences. The Hall of Flowers Palm Springs will take place on May 4-5, 2022, featuring new products, including a live resin line. Additionally, Canaccord Genuity's US Cannabis Symposium is set for May 11, 2022, where Andrew Thut will present at 8:00 AM ET. The Jefferies Conference NYC Cannabis Summit will occur on June 2, 2022, with opportunities for one-on-one meetings. For investor queries, contact IR@4frontventures.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
conferences
-
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, QTCQX: FFNTF) has successfully completed the acquisition of Island Global Holdings, Inc., a California producer of cannabis pre-rolls, flower, and concentrates. This strategic move enhances 4Front's brand portfolio with high-quality products and taps into Island's established customer base in the competitive California market. The leadership team from Island, including CEO Ray Landgraf, will integrate into 4Front's operations, aiming to deepen market penetration and explore further acquisitions. This acquisition aligns with 4Front's long-term growth strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) announces an immersive cannabis educational experience, the Trail to 4/20, launching on April 8, 2022, at Mission Dispensary South Chicago. This interactive art exhibit, created in collaboration with A.J. Tarzian, aims to educate attendees on the history and benefits of cannabis through engaging displays. Open to individuals 21 and older, guided tours will run Monday through Friday, from 11:00 a.m. to 4:00 p.m. CT, while self-guided tours are available until 8:00 p.m. CT. This initiative enhances 4Front's commitment to cannabis education and community engagement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.66%
Tags
none
-
Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF), a leading multi-state cannabis operator, announced its participation in two key upcoming conferences:

  • BTIG Global Cannabis Conference: April 6-7, 2022, featuring a fireside chat by Andrew Thut on April 6 at 10:30 AM ET.
  • Benzinga Cannabis Capital Conference: April 20-21, 2022, with a panel discussion on April 21 at 11:30 AM ET.

For investor relations, contact IR@4frontventures.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.09%
Tags
conferences
-
Rhea-AI Summary

4Front Ventures Corp. reported significant financial growth for FY 2021, with GAAP revenue rising 81% year-over-year to $104.6 million and Adjusted EBITDA surging 479% to $34.0 million. The company's Systemwide Pro Forma Revenue increased 50% to $132.7 million. Operational advancements include a new production facility in California, expected to drive future growth, and successful acquisitions like New England Cannabis Corporation. As of December 31, 2021, the company held $22.6 million in cash and strategic plans for expansion in key markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) will report its financial results for Q4 and full year 2021 on March 30, 2022, after market close. The company will host a conference call at 5:00 p.m. ET to discuss the results and current business trends. 4Front operates in key cannabis markets across California, Illinois, Massachusetts, Michigan, and Washington, and has established a strong reputation for its cultivation and production methodologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings

FAQ

What is the current stock price of 4Front Ventures (FFNTF)?

The current stock price of 4Front Ventures (FFNTF) is $0.0002 as of June 27, 2025.

What is the market cap of 4Front Ventures (FFNTF)?

The market cap of 4Front Ventures (FFNTF) is approximately 17.4M.
4Front Ventures Corp

OTC:FFNTF

FFNTF Rankings

FFNTF Stock Data

17.36M
448.45M
50.87%
6.73%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Phoenix